These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35868645)

  • 21. Cardiac manifestations of COVID-19 in Shenzhen, China.
    Zeng JH; Wu WB; Qu JX; Wang Y; Dong CF; Luo YF; Zhou D; Feng WX; Feng C
    Infection; 2020 Dec; 48(6):861-870. PubMed ID: 32725595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TB and COVID-19: paying attention to diabetes mellitus.
    Harries AD; Kumar AMV; Satyanarayana S; Lin Y; Dlodlo RA; Khogali M; Zachariah R; Kapur A
    Trans R Soc Trop Med Hyg; 2021 Jun; 115(6):600-602. PubMed ID: 34075400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).
    Zhou Y; Chi J; Lv W; Wang Y
    Diabetes Metab Res Rev; 2021 Feb; 37(2):e3377. PubMed ID: 32588943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes Mellitus and COVID-19: Review Article.
    Nassar M; Daoud A; Nso N; Medina L; Ghernautan V; Bhangoo H; Nyein A; Mohamed M; Alqassieh A; Soliman K; Alfishawy M; Sachmechi I; Misra A
    Diabetes Metab Syndr; 2021; 15(6):102268. PubMed ID: 34562865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
    Dorjee K; Kim H; Bonomo E; Dolma R
    PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of valvular and structural heart diseases during the coronavirus disease 2019 pandemic: an expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society.
    Płońska-Gościniak E; Suwalski P; Bartuś S; Kukulski T; Komar M; Wojakowski W; Grygier M; Pruszczyk P; Gąsior Z; Huczek Z; Berger-Kucza A; Bąk J; Sorysz D; Kasprzak JD
    Kardiol Pol; 2020 May; 78(5):498-507. PubMed ID: 32415767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presence of heart disease worsens prognosis in patients with COVID-19.
    San Román JA; Uribarri A; Amat-Santos IJ; Aparisi Á; Catalá P; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):773-775. PubMed ID: 32622732
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II).
    Maddaloni E; D'Onofrio L; Alessandri F; Mignogna C; Leto G; Pascarella G; Mezzaroma I; Lichtner M; Pozzilli P; Agrò FE; Rocco M; Pugliese F; Lenzi A; Holman RR; Mastroianni CM; Buzzetti R;
    Cardiovasc Diabetol; 2020 Oct; 19(1):164. PubMed ID: 33004045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
    Pugliese G; Vitale M; Resi V; Orsi E
    Acta Diabetol; 2020 Nov; 57(11):1275-1285. PubMed ID: 32865671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and Cardiovascular Comorbidities.
    Müller-Wieland D; Marx N; Dreher M; Fritzen K; Schnell O
    Exp Clin Endocrinol Diabetes; 2022 Mar; 130(3):178-189. PubMed ID: 33157558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Does having diabetes increase chances of contracting COVID-19 infection?".
    Gangopadhyay KK
    Diabetes Metab Syndr; 2020; 14(5):765-766. PubMed ID: 32512520
    [No Abstract]   [Full Text] [Related]  

  • 32. The value of clinical parameters in predicting the severity of COVID-19.
    Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
    J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.
    Silverii GA; Monami M; Cernigliaro A; Vigneri E; Guarnotta V; Scondotto S; Allotta VA; Conti M; Giordano C; Mannucci E
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):396-398. PubMed ID: 33223405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular System during SARS-CoV-2 Infection.
    Koźlik M; Błahuszewska A; Kaźmierski M
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection.
    Wu J; Zhang J; Sun X; Wang L; Xu Y; Zhang Y; Liu X; Dong C
    Diabetes Obes Metab; 2020 Oct; 22(10):1907-1914. PubMed ID: 32496012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study.
    Shah P; Magee K; Buccellato KH; Ismond M; Watson J
    Cardiovasc Diabetol; 2022 Feb; 21(1):24. PubMed ID: 35164745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covid-19 and Diabetes Mellitus.
    Attri B; Gupta Y; Tandon N
    Natl Med J India; 2021; 34(3):129-131. PubMed ID: 34825533
    [No Abstract]   [Full Text] [Related]  

  • 38. Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2.
    Alcocer-Gamba MA; Gutiérrez-Fajardo P; Sosa-Caballero A; Cabrera-Rayo A; Faradji-Hazan RN; Padilla-Padilla FG; Garnica-Cuellar JC; Hernández-Arispe LM; Reyes-Cianeros FA; León-Suárez A; de-Jesús-Rivera J; Mancillas-Adame L; Gaxiola-Macias M; Márquez-Rodríguez E; Miranda-Malpica E; Sanchez-Pedraza V; Lara-Martínez DS; Segovia-Palomo A; Nava-Hernández A; Rivera-Reyes R
    Arch Cardiol Mex; 2020; 90(Supl):77-83. PubMed ID: 32523151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes after SARS-CoV-2 infection.
    Al-Aly Z
    Lancet Diabetes Endocrinol; 2023 Jan; 11(1):11-13. PubMed ID: 36463908
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of incidence and risk profile for suffering Covid-19 infection by underlying conditions among middle-aged and older adults in Tarragona.].
    Vila-Córcoles Á; Ochoa-Gondar O; Torrente-Fraga C; Vila-Rovira Á; Satué-Gracia E; Hospital-Guardiola I; de Diego-Cabanes C; Gómez-Bertomeu F; Basora-Gallisà J
    Rev Esp Salud Publica; 2020 Jun; 94():. PubMed ID: 32588837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.